EUVIMED · CrossrefJournal
International Journal of Drug Regulatory Affairs
ISSN 2321-6794 · Society of Pharmaceutical Tecnocrats
Latest articles
Comparative Analysis of Cosmetic Labelling Requirements in the United States and Japan
Driving First‑Cycle ANDA Approvals Through Strategic Regulatory Planning
Application of Failure Modes and Effects Analysis (FMEA) for Conducting Multiple Risk Assessments in a New Pharmaceutical Facility
Comparative Analysis of Regulatory Approval Processes for Medical Devices in India and the European Union
Automated Classification of Post-Approval Changes Using Regulatory Intelligence Models
Regulatory Frameworks Governing Pharmaceutical Manufacturing Site Transfers: A Comparative Review of WHO, EMA, and US FDA Approaches
Drug Safety of Antihypertensive Medicines Using Pharmacovigilance Data: Signal Management Through Traditional Methods Versus Process Automation
A Comparative Study of Medical Device Regulatory Frameworks: India vs. the European Union
A Comparative Study of the Regulatory Landscape for Pre-filled Syringes (PFS) in the Philippines and Uganda
Regulatory Lifecycle Management of Solid Oral Dosage Forms in Nigeria and Kenya
Comparative Study of CTD Modules 3, 4, and 5: Generic Drugs versus Complex Generics (Liposomal Injectables) in the United States, European Union, and Japan
Lifecycle Continuity Through Regulatory Compliance: A Comparative Evaluation of Post-Approval Change Strategies for APIs and Drug Products Under the Regulatory Frameworks of Saudi Arabia, the United States, Australia, and Eurasia
An Analytical Study of Selected Bulk Drug Manufacturers in Andhra Pradesh and Telangana: SEZ Status, Regulatory Framework, Compliance, Oversight, and Workforce Welfare and Safety
Overview of Structural Specifications and Validation of eCTD (v3.2.2): Elucidation of the General Architecture of EU Module 1 and GCC Module 1
Regulatory Requirements for Participation in WHO Prequalification Programme for Parenteral Products
Bridging Regulatory Speed: A US–EU Perspective on Rapid Drug Approvals
The BIOSECURE Act: Key implications for U.S. Biotechnology, National security, and Federal funding
Between Statutes and Practice: Regulatory Capacity for Clinical Trials in The Gambia within the ECOWAS Regional Context
Comprehensive Comparison of Clinical Trial Protocol & Clinical Investigation Plan in Different Countries
Regulation of the Pharmaceutical Industry in Côte d'Ivoire and alignment with community development policies: realities and prospects for 2025
Global Regulatory Frameworks for Drug Approval: A Comparative Review of USFDA, EMA, and CDSCO
Electronic Common Technical Document (eCTD): Structure, Submission Process, and Regulatory Updates
Regulatory Affairs in Clinical Trials: Ethical, Legal, and Compliance Considerations
Pharmaceutical Regulatory Intelligence: Tools, Strategies, and Impact on Product Lifecycle Management
Reinventing Drug Development and Regulatory Affairs through Artificial Intelligence
Regulatory framework for fast track approval of Drugs in different countries
The Co-Sponsor in the conduct of a Clinical Trial in Germany
Phytopharmaceuticals Regulatory requirements and licensing process
A Comparative Study of Regulations of Nasal Products in the US and EU
A Comparative study of Regulations of Cell and Gene therapy in US, EU and India
EUVIMED